We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.AuthorsWen PY; Schiff D; Cloughesy TF; Raizer JJ; Laterra J; Smitt M; Wolf M; Oliner KS; Anderson A; Zhu M; Loh E; Reardon DAPublicationNeuro-oncology, 2011, Vol 13, Issue 4, p437ISSN1523-5866Publication typearticleDOI10.1093/neuonc/noq198